T. Rowe Price Associates
SKIN icon

T. Rowe Price Associates’s SkinHealth Systems SKIN Stock Holding History

T. Rowe Price Associates’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Buy
131,864
+21,153
+19% +$26K ﹤0.01% 2962
2025
Q4 		$154K Hold
110,711
– – ﹤0.01% 2872
2025
Q3 		$221K Sell
110,711
-59,338
-35% -$120K ﹤0.01% 2754
2025
Q2 		$325K Buy
170,049
+25,252
+17% +$35.6K ﹤0.01% 2497
2025
Q1 		$195K Buy
144,797
+30,650
+27% +$46.7K ﹤0.01% 2653
2024
Q4 		$182K Buy
114,147
+18,400
+19% +$28.9K ﹤0.01% 2719
2024
Q3 		$138K Buy
95,747
+19,300
+25% +$31.6K ﹤0.01% 2764
2024
Q2 		$147K Buy
76,447
+1,166
+2% +$3.28K ﹤0.01% 2669
2024
Q1 		$335K Buy
75,281
+5,934
+9% +$19.3K ﹤0.01% 2387
2023
Q4 		$216K Buy
69,347
+19,150
+38% +$71.9K ﹤0.01% 2513
2023
Q3 		$303K Buy
50,197
+4,237
+9% +$29.8K ﹤0.01% 2331
2023
Q2 		$385K Buy
45,960
+1,389
+3% +$14.4K ﹤0.01% 2253
2023
Q1 		$563K Sell
44,571
-3,226
-7% -$37.3K ﹤0.01% 2057
2022
Q4 		$435K Buy
47,797
+362
+0.8% +$3.91K ﹤0.01% 2195
2022
Q3 		$560K Buy
47,435
+11,317
+31% +$143K ﹤0.01% 2067
2022
Q2 		$464K Buy
36,118
+12,702
+54% +$170K ﹤0.01% 2249
2022
Q1 		$395K Buy
23,416
+11,436
+95% +$189K ﹤0.01% 2442
2021
Q4 		$289K Buy
+11,980
New +$309K ﹤0.01% 2604

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates's SKIN Position: Q1 2026 in Review

T. Rowe Price Associates increased its SkinHealth Systems (SKIN) stake by 19% in Q1 2026, buying an estimated $26K and bringing the position to 131,864 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #2962.

T. Rowe Price Associates first reported a position in SKIN in Q4 2021 and has held it in 18 quarters since. The position peaked at $563K in Q1 2023. 116 funds tracked by Wall St. Rank hold SKIN as of Q1 2026.

  • T. Rowe Price Associates held 131,864 shares of SkinHealth Systems worth $118K as of Q1 2026.
  • T. Rowe Price Associates bought 21,153 SkinHealth Systems shares in Q1 2026, an estimated $26K.
  • SkinHealth Systems made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2962 holding.
  • T. Rowe Price Associates first reported a position in SkinHealth Systems in Q4 2021 and has held it in 18 quarters since.
  • T. Rowe Price Associates's SkinHealth Systems position peaked at $563K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.